IRONWOOD PHARMACEUTICALS

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.
IRONWOOD PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ironwoodpharma.com
Total Employee:
501+
Status:
Active
Contact:
617-621-7722
Email Addresses:
[email protected]
Total Funding:
634 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Polaris Partners
Polaris Partners investment in Venture Round - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series F - Ironwood Pharmaceuticals
Morgan Stanley
Morgan Stanley investment in Series F - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series E - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series D - Ironwood Pharmaceuticals
GGV Capital
GGV Capital investment in Series D - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series C - Ironwood Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series C - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series B - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series A - Ironwood Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2021-12-01 | Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial Officer |
2021-08-03 | Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer |
2021-02-08 | Ironwood Pharmaceuticals Announces CEO Transition |
Official Site Inspections
http://www.ironwoodpharma.com Semrush global rank: 3.97 M Semrush visits lastest month: 3.12 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Ironwood Pharmaceuticals"
Leadership - Ironwood Pharmaceuticals
Mr. Minardo has served as our chief legal officer since August 2021. Prior to joining Ironwood, Mr. Minardo was with Seqirus, a pharmaceutical company, where he was vice president, general โฆSee details»
Ironwood Pharmaceuticals, Inc. - Company Overview
5 days ago [email protected]. Corporate Overview. Ironwood Pharmaceuticals (Nasdaq: IRWD), is a biotechnology company developing and commercializing life-changing โฆSee details»
Ironwood Pharmaceuticals - LinkedIn
Ironwood Pharmaceuticals Biotechnology Research Boston, MA 31,430 followers Ironwood is on a mission to advance treatment of gastrointestinal diseases & redefine the standard of care for patientsSee details»
Ironwood Pharmaceuticals - Wikipedia
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald Fink at the โฆSee details»
Ironwood Pharmaceuticals SuccessStory
When it was started, it was just a group of 9 Ph.D. scientists who worked for the company and it soon expanded to an organization that is fully-integrated and highly commercialized.Its name โฆSee details»
Ironwood Pharmaceuticals Announces Leadership Updates
Jun 7, 2021 She built a strong and effective finance organization, and today, Ironwood is proud to have delivered two years of profitability, supported by a robust balance sheet and strong โฆSee details»
Ironwood Pharmaceuticals - Crunchbase Company โฆ
Contact Email [email protected] Phone Number 617-621-7722 Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines.See details»
Ironwood Pharmaceuticals GmbH โ Swiss Biotech
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.See details»
Company Overview - Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on a mission to push the boundaries of the gastrointestinal (GI) field by advancing the treatment of GI diseases and redefining the standard of care for millions of โฆSee details»
Company - Ironwood Pharmaceuticals
Ironwood Pharmaceuticals. Close. SearchSee details»
Governance and Nominating Committee
Governance and Nominating Committee. Download item year listSee details»
Ironwood Pharmaceuticals Inc - Company Profile - GlobalData
Website www.ironwoodpharma.com Telephone 1 617 6217722. No of Employees 267. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange IRWD (NASD) Revenue (2024) โฆSee details»
Ironwood Pharmaceuticals Company Profile - Office Locations ...
Ironwood Pharmaceuticals has 5 employees across 2 locations and $351.41 m in annual revenue in FY 2024. See insights on Ironwood Pharmaceuticals including office locations, competitors, โฆSee details»
Ironwood Pharmaceuticals - Overview, News & Similar companies ...
Jun 23, 2024 Ironwood Pharmaceuticals contact info: Phone number: (617) 621-8097 Website: www.ironwoodpharma.com What does Ironwood Pharmaceuticals do? Ironwood โฆSee details»
Ironwood Pharmaceuticals Announces Leadership Updates
Jun 7, 2021 Investors and Media: Meredith Kaya, 617-374-5082 [email protected] Matt Roache, 617-621-8395 [email protected] Media: Beth Calitri, 978-417 โฆSee details»
Working at Ironwood - Ironwood Pharmaceuticals
WORKING AT IRONWOOD PHARMACEUTICALS When I think of all of the work Ironwood as an organization has done to impact patients and impact their lives positively, that is a huge โฆSee details»
Working at Ironwood Pharmaceuticals - Zippia
Mar 14, 2024 www.ironwoodpharma.com. Organization Type. Public. CEO. Thomas McCourt. Social Media. Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, โฆSee details»
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
5 days ago BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people โฆSee details»
Overview - Ironwood Pharmaceuticals
Our culture is one that prioritizes sustainability in everything we do. From recruiting and retaining our talented employees, to overseeing our internal processes, to remaining mindful of our โฆSee details»
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission ...
Jan 29, 2025 To access the webcast, please visit the Investors section of Ironwoodโs website at www.ironwoodpharma.com. The call will be available for replay via telephone starting at โฆSee details»